NCT00748124

Brief Summary

To evaluate the safety and effectiveness of Confluent Surgical's PleuraSeal Sealant System in the treatment and control of intra and postoperative air leaks following pulmonary resection via an open thoracotomy. The performance of the PleuraSeal Sealant System as an adjunct to conventional closure techniques (i.e. surgical staples or sutures) will be compared to conventional surgical techniques alone.

Trial Health

57
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
230

participants targeted

Target at P25-P50 for phase_3

Timeline
Completed

Started Aug 2008

Typical duration for phase_3

Geographic Reach
1 country

1 active site

Status
terminated

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

August 1, 2008

Completed
1 month until next milestone

First Submitted

Initial submission to the registry

September 4, 2008

Completed
4 days until next milestone

First Posted

Study publicly available on registry

September 8, 2008

Completed
2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

September 1, 2010

Completed
7 months until next milestone

Study Completion

Last participant's last visit for all outcomes

April 1, 2011

Completed
Last Updated

September 11, 2014

Status Verified

September 1, 2014

Enrollment Period

2.1 years

First QC Date

September 4, 2008

Last Update Submit

September 4, 2014

Conditions

Outcome Measures

Primary Outcomes (1)

  • Proportion of subjects remaining air leak free from time of skin closure to hospital discharge.

    75 days

Study Arms (2)

PleuraSeal Sealant Device

EXPERIMENTAL
Device: PleuraSeal Sealant SystemProcedure: Standard Tissue Closure Techniques

Control

OTHER
Procedure: Standard Tissue Closure Techniques

Interventions

Lung Sealant Device + standard tissue closing techniques (sutures/staples)

PleuraSeal Sealant Device

Standard tissue closure techniques (sutures/ staples) alone

ControlPleuraSeal Sealant Device

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Elective pulmonary lobectomy, segmental and/or wedge resection in one or more lobes via an open thoracotomy

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Confluent Surgical

Bedford, Massachusetts, 01730, United States

Location

Study Design

Study Type
interventional
Phase
phase 3
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
INDUSTRY
Responsible Party
SPONSOR

Study Record Dates

First Submitted

September 4, 2008

First Posted

September 8, 2008

Study Start

August 1, 2008

Primary Completion

September 1, 2010

Study Completion

April 1, 2011

Last Updated

September 11, 2014

Record last verified: 2014-09

Locations